MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease

S. Kolipaka, H. Kong, P. Izbicki (Boca Raton, USA)

Meeting: 2025 International Congress

Keywords: Depression, Parkinson’s, Voice tremor

Category: Parkinson's Disease (Other)

Objective: This review assesses the effects of choral singing as an adjunct therapy for Parkinson’s disease (PD).

Background: PD is the second-most common neurodegenerative disease, but no disease-modifying pharmacologic agents have yet been developed as treatment. Adjunct therapies remain critical in the standard of care for persons with PD and are used in combination with medication for management of PD symptoms. One such intervention, choral singing or group singing, is an increasingly popular therapy for individuals with Parkinson’s Disease.

Method: The framework used for this review was the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews Checklist (PRISMA-SC). The search was performed using the NCBI database with the search terms: “choral singing” OR “group singing” AND “Parkinson.” The initial search produced 26 results. The search was filtered to include only articles published within the last 10 years, reducing the pool to 21. The results were narrowed to 10 due to duplicates, studies not including PD, and studies not focused on choral/group singing. The final 10 studies with total of 238 patients were reviewed for the effects of choral singing on Parkinson’s disease. Key information included study design, sample size, intervention details, and outcomes related to motor, cognitive, and psychological domains.

Results: The majority (90%, 9/10) of trials note significant improvements in quality of life. 7/10 (70%) articles noted improvement in psychological domains regarding mood. 5/10 (50%) noted improvement in physical domains, specifically vocal quality. One study (1/10, 10%) with a virtual choir found no improvement to quality of life in psychological or motor domains. 10% (1/10) of the studies examined noted improvement in cognition.

Conclusion: Choral singing has shown significant improvement in addressing symptoms of PD in quality of life, mood, and vocal quality. Limitations include varied approaches to implementing group singing and variations in outcomes assessed. Further research should be done on possible cognitive improvements and standardized approaches to implementing choral singing. Choral singing is a complementary intervention with a low risk safety profile and is effective at improving quality of life and speech-symptoms. It shows promise as a useful intervention for clinicians to recommend to patients.

To cite this abstract in AMA style:

S. Kolipaka, H. Kong, P. Izbicki. Is It Better to Sing Together? A Review of Choral Singing for People with Parkinson’s Disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/is-it-better-to-sing-together-a-review-of-choral-singing-for-people-with-parkinsons-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/is-it-better-to-sing-together-a-review-of-choral-singing-for-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley